Biochemical Characterization of PER-2 and Genetic Environment of bla PER-2
- 1 July 2007
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 51 (7), 2359-2365
- https://doi.org/10.1128/aac.01395-06
Abstract
PER-2 was the first detected and the second most prevalent extended-spectrum β-lactamase in clinical pathogens isolated in Argentina and was also reported only in other South American countries. Citrobacter freundii 33587 was isolated in 1999 in Buenos Aires and was resistant to all tested β-lactams except cephamycins and carbapenems. The strain produced both plasmid-borne TEM-1 and PER-2 (pI 5.4), which could be transferred by conjugation. By PCR screening, thermal asymmetric interlaced PCR, and DNA sequencing, we detected an IS Pa12 /IS 1387a insertion sequence upstream of bla PER-2 , previously reported as also being associated with bla PER-1 . The presence of similar structures upstream of bla PER-1 and bla PER-2 suggests a common origin and mobilization. Compared to bla PER-1 genes, an additional putative promoter for bla PER-2 was found. PER-2 kinetic analysis showed its high hydrolysis efficiencies toward both CTX and CAZ ( k cat / K m , 0.76 and 0.43 μM −1 ·s −1 , respectively).Keywords
This publication has 38 references indexed in Scilit:
- Emergence of PER-2 and VEB-1a in Acinetobacter baumannii Strains in the AmericasAntimicrobial Agents and Chemotherapy, 2006
- Biochemical and Molecular Characterization of Three New Variants of AmpC β-Lactamases from Morganella morganiiAntimicrobial Agents and Chemotherapy, 2006
- Genetic analysis of a multiresistant strain of Pseudomonas aeruginosa producing PER-1 β-lactamaseClinical Microbiology & Infection, 2006
- Description of In116, the first blaCTX-M-2-containing complex class 1 integron found in Morganella morganii isolates from Buenos Aires, ArgentinaJournal of Antimicrobial Chemotherapy, 2005
- Multifocal Detection of Multidrug-Resistant Pseudomonas aeruginosa Producing the PER-1 Extended-Spectrum β-Lactamase in Northern ItalyJournal of Clinical Microbiology, 2004
- Emerging Extended-Spectrum β-Lactamases in Proteus mirabilisJournal of Clinical Microbiology, 2002
- Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance ThreatClinical Microbiology Reviews, 2001
- Third-Generation Cephalosporin Resistance inShigella sonnei, ArgentinaEmerging Infectious Diseases, 2001
- The High Resolution Crystal Structure for Class A β-Lactamase PER-1 Reveals the Bases for Its Increase in Breadth of ActivityJournal of Biological Chemistry, 2000
- Site-directed mutagenesis of residues 164, 170, 171, 179, 220, 237 and 242 in PER-1 β-lactamase hydrolysing expanded-spectrum cephalosporinsProtein Engineering, Design and Selection, 1999